We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Ash Board PhD

Ash Board PhD

Editorial Director


Ash started with Technology Networks as an editor in 2010 having previously worked in marketing communications roles within the scientific industry. He holds a PhD in Chemistry from the University of Nottingham where he researched the active site of enzymes. Ash oversees the editorial, social media and custom content teams, helping set the direction of the publication.


Got a question for Ash Board PhD?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 36
Designing in Sustainability in Science content piece image
Industry Insight

Designing in Sustainability in Science

With a reliance on single-use plastics, significant waste and high energy usage, the carbon footprint of the biopharma industry is large. If we are to accelerate the path to net zero, it is therefore critical to ensure sustainability in science.
Accelerating Preclinical Biologics Development content piece image
Industry Insight

Accelerating Preclinical Biologics Development

Quick to Clinic from Thermo Fisher Scientific aims to accelerate preclinical development, enabling more rapid biologic drug development. To learn more about this solution, we spoke to Paul Jorjorian.
Unlocking New Possibilities for Proteomics Researchers content piece image
Industry Insight

Unlocking New Possibilities for Proteomics Researchers

Thermo Scientific Proteome Discoverer 3.0 software offers a wide range of comprehensive tools for proteomics studies. In this interview, we learn more about the latest version, how it leverages artificial intelligence and what this means for proteomics researchers.
A Path to Net Zero content piece image
Industry Insight

A Path to Net Zero

Agilent recently announced its commitment to achieve net-zero greenhouse gas emissions no later than 2050. We spoke to them to learn how you go about making a global company with 16,300 employees a net-zero business.
Advancing the Understanding of hPSC-CM Biology With Multiomics content piece image
Article

Advancing the Understanding of hPSC-CM Biology With Multiomics

In a recent study, a new multiomics method for analyzing the hPSC-CM metabolome and proteome is described, which could greatly help to advance the understanding of hPSC-CM biology. In this interview, the lead author of the study, Elizabeth F. Bayne, tells us more about the method and its significance.
Overcoming Challenges of Biologic Characterization content piece image
Industry Insight

Overcoming Challenges of Biologic Characterization

To learn more about the Biophase 8800 system and how it can help to overcome current bioanalytical challenges, Technology Networks spoke to Mani Krishnan, vice president and general manager, SCIEX CE and Biopharma.
Genomic Testing Service To Drive Personalized Medicine for Cancer Patients content piece image
Industry Insight

Genomic Testing Service To Drive Personalized Medicine for Cancer Patients

The service will enable oncologists, hematologists and other healthcare professionals to undertake rapid and extensive genomic analysis of cancer samples on an unprecedented scale in the UK.
Improved Characterization of Antibody-Drug Conjugates content piece image
Article

Improved Characterization of Antibody-Drug Conjugates

In a new research study published in Analytical Chemistry, scientists showcase a novel mass spectrometry-based method that enables high-throughput characterization of ADCs. Technology Networks spoke to Eli J. Larson, lead author of the paper, to learn more about the method and some of the benefits it offers over existing analytical techniques.
Addressing the Challenges of Small Molecule Analysis content piece image
Industry Insight

Addressing the Challenges of Small Molecule Analysis

Despite small molecule research spanning many fields, the characterization and identification protocols are often not as good as they should be. We spoke to Andreas Huhmer from Thermo Fisher Scientific to learn how the company's latest mass spectrometer helps address these issues.
Opinionated Science Episode 17: I Got COVID-19: Here's What Happened content piece image
Podcast

Opinionated Science Episode 17: I Got COVID-19: Here's What Happened

This episode is a COVID-19 podcast with a first-hand focus. Podcast host Ruairi Mackenzie discusses his experience with symptomatic COVID-19. And we also look at the data around COVID-19 risk and age and discuss the emerging problems posed by long COVID.
Advertisement